Clinical Trial Update: Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing SPD489 for safety and efficacy on executive function behaviors in adults with ADHD and executive function impairment; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• SPD489

Snippet

Sponsor: Shire | Conditions: ADHD Specifically With Executive Function Impairment | Phase 4 | Status: COMPLETED | Results posted: 2012-02-13